• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of the Efficacy and Safety of Oral Anticoagulants in East Asians With Atrial Fibrillation.

作者信息

Uchiyama Shinichiro

机构信息

Clinical Research Center for Medicine, International University of Health and Welfare, Center for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Center.

出版信息

Circ J. 2015;79(12):2537-8. doi: 10.1253/circj.CJ-15-1117. Epub 2015 Nov 5.

DOI:10.1253/circj.CJ-15-1117
PMID:26538470
Abstract
摘要

相似文献

1
Comparison of the Efficacy and Safety of Oral Anticoagulants in East Asians With Atrial Fibrillation.东亚地区心房颤动患者口服抗凝剂的疗效与安全性比较
Circ J. 2015;79(12):2537-8. doi: 10.1253/circj.CJ-15-1117. Epub 2015 Nov 5.
2
Stroke prevention in atrial fibrillation: an Asian perspective.心房颤动的卒中预防：亚洲视角
Thromb Haemost. 2014 May 5;111(5):789-97. doi: 10.1160/TH13-11-0948. Epub 2014 Feb 6.
3
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.新型口服抗凝剂与华法林治疗心房颤动患者的疗效和安全性比较：随机试验的荟萃分析。
Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4.
4
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.ENGAGE AF-TIMI 48 试验中亚洲与非亚洲房颤患者的临床结局、依度沙班浓度和抗 Xa 因子活性比较。
Eur Heart J. 2019 May 14;40(19):1518-1527. doi: 10.1093/eurheartj/ehy807.
5
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.当代口服抗凝剂在亚洲非瓣膜性心房颤动患者中的疗效和安全性。
Stroke. 2019 Aug;50(8):2245-2249. doi: 10.1161/STROKEAHA.119.025536. Epub 2019 Jun 18.
6
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.非维生素K拮抗剂口服抗凝药在亚洲房颤患者中的有效性和安全性
Stroke. 2017 Nov;48(11):3040-3048. doi: 10.1161/STROKEAHA.117.018773. Epub 2017 Oct 3.
7
Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.非维生素 K 拮抗剂口服抗凝剂与华法林在伴有房颤和既往卒中或短暂性脑缺血发作的患者中的比较：一项更新的随机对照试验的系统评价和荟萃分析。
Int J Stroke. 2017 Aug;12(6):589-596. doi: 10.1177/1747493017700663. Epub 2017 Mar 15.
8
Recurrent Ischemic Stroke and Cardiovascular Outcomes in Patients With Atrial Fibrillation With Ischemic Stroke Despite Direct Oral Anticoagulants.尽管使用了直接口服抗凝剂，但仍发生缺血性卒中的心房颤动患者的复发性缺血性卒中和心血管结局
Stroke. 2023 Apr;54(4):e145-e146. doi: 10.1161/STROKEAHA.122.041197. Epub 2023 Feb 28.
9
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.直接口服抗凝剂在亚洲透析人群中的有效性和安全性：基于人群的队列研究和荟萃分析。
Cardiovasc Drugs Ther. 2021 Oct;35(5):975-986. doi: 10.1007/s10557-020-07108-4. Epub 2020 Nov 19.
10
Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".陈和萧就文章《口服抗凝剂在有颅内出血病史的心房颤动患者中预防卒中的应用》所写的信。
Circulation. 2016 Sep 13;134(11):e226-7. doi: 10.1161/CIRCULATIONAHA.116.022923.